Start Date
July 12, 2021
Primary Completion Date
April 1, 2022
Study Completion Date
April 1, 2022
No intervention
No study intervention will be administered as part of this study.
Clinical Trial Site, Salt Lake City
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY